— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

Pfizer Inc

Q2 2026 · Filed 2026-08-13
Market Value
$159M
-29.7%
Holdings
16
-1
New Purchases
0
Added To
0
Closed
1
Reduced
3
Top 10 Concentration
97.4%
Turnover
6.2%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
PYXS 12.22% 4.06% +8.16% $19M
ALLO 29.44% 21.95% +7.48% $47M
CELC 18.54% 13.82% +4.72% $30M
BHVN 5.02% 1.87% +3.16% $8M
ARVN 17.35% 15.40% +1.96% $28M
ZNTL 2.42% 0.88% +1.53% $4M
CRBU 4.94% 3.68% +1.26% $8M
SPRO 3.35% 2.43% +0.92% $5M
AGMB 0.65% 0.36% +0.29% $1M
CRDF 1.89% 1.65% +0.24% $3M
BOLT 0.08% 0.06% +0.02% $134K
DNA 0.02% 0.01% +0.01% $30K

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
ORIC 2.23% 25.42% -23.19% $4M
ZURA 1.81% 7.42% -5.61% $3M
NXTC 0.05% 0.68% -0.63% $73K
QTTB 0.00% 0.32% -0.32% $0

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 1 $30M 18.5%
Small Cap 7 $90M 56.5%
Micro Cap 8 $40M 24.9%

Portfolio Analytics

Avg Market Cap
$637M
Median Market Cap
$318M
Avg P/E
16.8
Median P/E
8.5
Avg Dividend Yield
—%
Avg Beta
1.28
# Stocks
16
# ETFs / Funds
0

Top Holdings (16 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 ALLO 29.44% 22,032,040 $47M $2.13 -$3M — —
2 CELC 18.54% 295,652 $30M $99.95 -$2M — —
3 ARVN 17.35% 3,457,815 $28M $8.00 -$7M — —
4 PYXS 12.22% 7,032,770 $19M $2.77 $10M — —
5 BHVN 5.02% 505,645 $8M $15.83 $4M — —
6 CRBU 4.94% 4,690,431 $8M $1.68 -$469K — —
7 SPRO 3.35% 2,362,348 $5M $2.26 -$165K — —
8 ZNTL 2.42% 953,834 $4M $4.04 $2M — —
9 ORIC 2.23% 372,904 $4M $9.53 -$54M -4,407,497 -92.2%
10 CRDF 1.89% 2,411,575 $3M $1.25 -$723K — —
11 ZURA 1.81% 538,841 $3M $5.35 -$14M -2,300,072 -81.0%
12 AGMB 0.65% 75,000 $1M $13.81 $222K — —
13 BOLT 0.08% 31,305 $134K $4.28 -$3K — —
14 NXTC 0.05% 44,347 $73K $1.65 -$1M -109,007 -71.1%
15 DNA 0.02% 2,928 $30K $10.25 $13K — —
16 QTTB —% — — — -$737K -101,618 -100.0% SOLD

Sold Out Positions

SymbolValue% Port
QTTB — —%
View SEC EDGAR Filings for Pfizer Inc →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms